PSMA-T4 kit for Tc-99m labelling clinical trials

An open-label phase 2/3 study to analyse the feasibility and evaluate the safety of intravenous administration of 99mTc-PSMA-T4 in patients with prostate cancer

This study is testing a new way to find and treat prostate cancer using a special scan. Researchers want to see if this new method is safe and works well to spot cancer cells in men with prostate cancer.